Tura Aysegül, Merz Hartmut, Reinsberg Mihaela, Lüke Matthias, Jager Martine J, Grisanti Salvatore, Lüke Julia
Department of Ophthalmology, University of Lübeck, Lübeck, Germany.
Department of Pathology, University of Lübeck, Lübeck, Germany.
Pigment Cell Melanoma Res. 2016 Sep;29(5):583-9. doi: 10.1111/pcmr.12507.
Monosomy-3 in primary uveal melanoma (UM) is associated with a high risk of metastasis and mortality. Although circulating melanoma cells (CMC) can be found in most UM patients, only approximately 50% of the patients develop metastases. We utilized a novel immuno-FISH assay to detect chromosome-3 in intact CMC isolated by dual immunomagnetic enrichment. Circulating melanoma cells were detected in 91% of the patients (n = 44) with primary non-metastatic UM, of which 58% were positive for monosomy-3. The monosomy-3 status of CMC corresponded to the monosomy-3 status of the primary tumor in 10 of the 11 patients where this could be tested. Monosomy-3 in the CMC was associated with an advanced tumor stage (P = 0.046) and was detected in all four patients who developed metastasis within the follow-up period of 4 yr. This non-invasive technique may enable the identification of UM patients at risk for metastasis particularly when a primary tumor specimen is unavailable.
原发性葡萄膜黑色素瘤(UM)中的3号染色体单体与转移和死亡的高风险相关。尽管在大多数UM患者中都能发现循环黑色素瘤细胞(CMC),但只有约50%的患者会发生转移。我们采用了一种新型免疫荧光原位杂交检测方法,以检测通过双重免疫磁珠富集分离出的完整CMC中的3号染色体。在91%的原发性非转移性UM患者(n = 44)中检测到了循环黑色素瘤细胞,其中58%的细胞3号染色体单体呈阳性。在11例可进行检测的患者中,有10例CMC的3号染色体单体状态与原发性肿瘤的3号染色体单体状态相符。CMC中的3号染色体单体与肿瘤晚期相关(P = 0.046),并且在随访4年期间发生转移的所有4例患者中均检测到了3号染色体单体。这种非侵入性技术可能有助于识别有转移风险的UM患者,尤其是在无法获得原发性肿瘤标本的情况下。